RI
ELDN icon

RTW Investments’s Eledon Pharmaceuticals ELDN Stock Holding History

RTW Investments’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-17,570
Closed -$1.48M – 49
2018
Q3 		$1.48M Buy
17,570
+803
+5% +$82K 0.09% 43
2018
Q2 		$2.11M Buy
16,767
+100
+0.6% +$10.3K 0.15% 36
2018
Q1 		$1.51M Buy
+16,667
New +$1.23M 0.14% 36

Other funds holding ELDN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CSPIA
Cary Street Partners Investment Advisory Richmond, Virginia $494M AUM 27.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RTW Investments's ELDN Position: Q4 2018 in Review

RTW Investments sold out of Eledon Pharmaceuticals (ELDN) in Q4 2018, closing a stake of 17,570 shares — an estimated $1.48M sold.

RTW Investments first reported a position in ELDN in Q1 2018 and held it in 3 quarters. The position peaked at $2.11M in Q2 2018. 16 funds tracked by Wall St. Rank hold ELDN as of Q4 2018.

  • RTW Investments reported no remaining Eledon Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • RTW Investments sold 17,570 Eledon Pharmaceuticals shares in Q4 2018, an estimated $1.48M.
  • RTW Investments first reported a position in Eledon Pharmaceuticals in Q1 2018 and held it in 3 quarters.
  • RTW Investments's Eledon Pharmaceuticals position peaked at $2.11M in Q2 2018.
  • 16 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q4 2018.

Based on RTW Investments's 13F filing for Q4 2018, filed 14 Feb 2019.